Physician Directory

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Ralph Philip Ermoian, MD

Dr. Ermoian is a radiation oncologist who treats pediatric patients with brain tumors, blood tumors requiring stem cell transplants, and salivary gland tumors at UW Medical Center, Seattle Children's, and SCCA Proton Therapy.

Patient Care Philosophy:

I want to provide the same care that I would want and expect of my own health-care providers if I had cancer: compassionate, detail-oriented, and patient-centered care that is tailored to the patient’s medical needs and goals.

Dr. Ermoian's Resume


Title

  • Medical Director, Radiation Oncology, Seattle Children’s Hospital
  • Assistant Professor, Radiation Oncology, University of Washington School of Medicine
  • Radiation Oncologist, University of Washington Medical Center
  • Radiation Oncologist, SCCA Proton Therapy, A ProCure Center

Clinical Expertise

Pediatric patients, brain tumors, salivary gland tumors, pediatric and adult patients with blood tumors requiring stem cell transplants

Experience

Dr. Ermoian's research involves a number of studies examining the outcomes of pediatric patients treated with radiation therapy including patients with brain tumors, blood tumors requiring stem cell transplants, and salivary gland tumors.

Education And Training

  • Medical Education: UCSF School of Medicine 
  • Residency: University of Washington Radiation Oncology
  • Internship: Children’s Hospital, Boston
    Pediatrics
  • Pediatrics Residency: University of Calif. San Francisco

More Information

Dr. Ermoian is board certified in Pediatrics and Radiation Oncology.

Dr. Ermoian's Story


Dr. Ermoian was a civil engineer when a close family member became ill. 

"As I spent time with her and her doctors, I realized I wanted to become a physician," he says. "Somehow I knew from the first days of medical school that I wanted to care for cancer patients.  Caring for patients with cancer combines opportunities to make progress on treating terrible diseases while hopefully making an important difference to people."

Dr. Ermoian's research involves a number of studies examining the outcomes of pediatric patients treated with radiation therapy including patients with brain tumors, blood tumors requiring stem cell transplants, and salivary gland tumors.

In his lifetime, Dr. Ermoian expects that physicians will be able to use molecular profiles of cancer to choose the combination of therapies for individual patients that maximizes effectiveness while minimizing side effects. 

"I expect radiation treatment to become increasingly targeted to avoid treating healthy tissue while delivering stronger dose to cancer," he says.

Outside of work, Dr. Ermoian enjoys spending time with his wife and daughter, hiking, bike riding, and baking.